Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Company announcement – No. 17 / 2020 Zealand Pharma major shareholder announcement: Wellington Management Group LLP Copenhagen, April 6, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no....
-
Company announcement – No. 16 / 2020 Zealand Pharma’s Annual General Meeting 2020 Copenhagen, April 3, 2020 – Yesterday, Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), held its...
-
Company announcement – No. 15 / 2020 Zealand Pharma completes the acquisition of Valeritas Zealand Pharma (NASDAQ: ZEAL) has acquired Valeritas Holdings, Inc. (NASDAQ: VLRX), a U.S. based...
-
Company announcement – No. 14 / 2020 Zealand Pharma provides business update related to current COVID-19 situation Strong progress in discovery and clinical pipeline, with positive Phase 2 results...
-
Company announcement – No. 13 / 2020 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
-
Company announcement – No. 13 / 2020 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
-
Company announcement – No. 12 / 2020 Total number of shares and voting rights in Zealand Pharma at March 31, 2020 Copenhagen, March 31, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no....
-
Press Release – No. 04 / 2020 Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal® Rescue Pen for treatment of severe hypoglycemia The...
-
Company announcement – No. 11 / 2020 Zealand Pharma completes subscription of New Ordinary Shares and registration of capital increase Copenhagen, March 31, 2020 – In reference to Zealand Pharma A/S...
-
Company announcement – No. 09 / 2020 Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 137,236,000 A total of 741,816 new shares (the...